• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 30, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

A simulator allows patients to experiment how their vision will improve before surgery

Bioengineer by Bioengineer
February 7, 2019
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The new technology, which is about to launched on the market, consists of a lightweight binocular helmet

IMAGE

Credit: YAIZA GONZÁLEZ/ CSIC Communication

The details regarding the validation of this new device are published in the latest issue of Scientific Reports.

Multifocal lenses are used in cataract surgeries – to replace the crystalline when it has lost its transparency – or to correct for presbyopia. There are different lens designs in the market, and choosing one or another depends on each patient’s tolerance and preference.

“The possibility of the patient experimenting vison with a multifocal lens before the surgery is very attractive to reduce uncertainty and to manage expectations”, ensures CSIC researcher Susana Marcos, who works at the Institute of Optics. Her team at the Visual Optics and Biophotonics Laboratory has spent years developing technologies of simultaneous vision simulation aiming at evaluating visual quality with new designs of multifocal lenses before they are implanted or even manufactured.

Now, they are introducing SimVis, a lightweight binocular visual simulator which is autonomous and wearable in helmets. In the article, scientists show the equivalence between the vision provided by their device and the intraocular lenses. In other words, lenses are depicted in the simulator.

A realistic experience

“Visual simulators are an ideal technique to provide patients with a new realistic experience of multifocality before the implantation of a new intraocular lens. In addition, if the simulator is miniaturized and has a more practical design than the ones currently available in the market, benefits could multiply”, adds Marcos.

Researchers validated the simulator’s realism in a group of patients by comparing the visual acuity obtained at different distances through a commercial trifocal lens – with focal points for close, intermediate and long focal distances – and through the same lens simulated by a spatial light modulator (another simulating technology) and by SimVis . “The response to multifocality depends on the subjects, but the real trifocal lens and the simulated one offered the same visual response through-focus in each patient”, concludes CSIC researcher María Viñas, first author of the article.

The new simulator can be wirelessly controlled by a mobile application or a tablet. With this program it is possible not just controlling the device’s lenses, but also to track the functional tests conducted on each patient wherever they are.

The technology developed by this group of CSIC scientists is protected by four patents – one of them received the award “Premio a la Mejor Patente del Año” from the Madrid+d Foundation – owned by CSIC, and licensed to the company 2EyesVision S.L., a spin-off founded, among others, by some of the study researchers.

###

Media Contact
Alda Ólafsson
[email protected]
34-915-681-499

Related Journal Article

http://dx.doi.org/10.1038/s41598-019-38673-w

Tags: Medicine/HealthOphthalmologyOptics
Share12Tweet8Share2ShareShareShare2

Related Posts

PFAS Levels Linked in Water and Southern California Adults

October 30, 2025

ECM, ROCK, and Polarity Orchestrate Lung Growth

October 30, 2025

Experts Convene at National Summit to Unveil Groundbreaking Strategies for Reducing Firearm-Related Harms

October 30, 2025

PRRFCT Match: Virtual Support for Young Children

October 30, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1292 shares
    Share 516 Tweet 323
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    312 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    202 shares
    Share 81 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    136 shares
    Share 54 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

PFAS Levels Linked in Water and Southern California Adults

ECM, ROCK, and Polarity Orchestrate Lung Growth

Cluster Analysis Links Body Composition, Child Health Risks

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.